Bausch + Lomb Corporation Q4 2025 Earnings Call Summary

Core Insights - The company reduced its global headcount by approximately 500 positions year-over-year to create a more efficient organizational structure that supports growth [1] - The dry eye franchise has transitioned from a launch phase to a growth phase, focusing on targeted investments and selling excellence to enhance Miebo and Xiidra performance [1] Financial Performance - The company achieved record Q4 performance with 7% constant currency revenue growth and 27% adjusted EBITDA growth, indicating significant operating leverage from a more fixed cost infrastructure [3] - Margin expansion is attributed to 'Vision 27' initiatives, which improved product mix towards higher-margin offerings and enhanced pricing discipline across all segments [3] - Projected 2026 revenue is between $5.375 billion and $5.475 billion, with expectations that each business segment will grow faster than its respective market [3] - Anticipated adjusted EBITDA growth of approximately 15%, nearly three times the rate of revenue growth, targeting a 19% margin at the midpoint [3] Market Position and Strategy - The company leveraged a diversified 'end-to-end' eye health portfolio to outperform the global contact lens market, achieving 7% growth in China despite broader consumer softness [2] - Successfully navigated the voluntary enVista recall, returning the Implantables business to Q1 2025 levels ahead of schedule through strong surgeon trust and uptake of the Envy and Aspire platforms [2] - The company plans to launch the 'Halo' bioactive contact lens material in 2028 following successful top-line data from the first external clinical study [3] Future Outlook - Seasonality is expected to become more pronounced in 2026, with Q1 projected as the lowest point and Q4 as the highest, driven by the increasing prominence of the prescription dry eye business [3] - Forecasting a step-down in capital expenditures to approximately 5% to 6% of revenue in 2026, supporting a target of over 50% cash flow conversion by 2028 [3]